We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+3.69%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$14.1B
AUM Growth
-$90M
Cap. Flow
-$394M
Cap. Flow %
-2.79%
Top 10 Hldgs %
21.48%
Holding
1,980
New
111
Increased
767
Reduced
962
Closed
123

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.3M
2
AAPL icon
Apple
AAPL
+$12.5M
3
LVS icon
Las Vegas Sands
LVS
+$10.1M
4
XOM icon
ExxonMobil
XOM
+$9.07M
5
ADP icon
Automatic Data Processing
ADP
+$7.98M

Sector Composition

Rank Sector Weight
1 Technology 28.17%
2 Healthcare 8.93%
3 Consumer Discretionary 8.08%
4 Financials 7.53%
5 Communication Services 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
J icon
1151
Jacobs Solutions
J
$17.1B
$937K 0.01%
8,110
-841
-9% -$98.6K
ROK icon
1152
Rockwell Automation
ROK
$49.2B
$937K 0.01%
3,403
-869
-20% -$235K
KTOS icon
1153
Kratos Defense & Security Solutions
KTOS
$11.2B
$935K 0.01%
46,712
-3,225
-6% -$63K
MDGL icon
1154
Madrigal Pharmaceuticals
MDGL
$11.8B
$934K 0.01%
3,335
+365
+12% +$86.9K
SVM
1155
Silvercorp Metals
SVM
$2.5B
$930K 0.01%
276,719
+64,700
+31% +$234K
TDW icon
1156
Tidewater
TDW
$4.1B
$930K 0.01%
9,764
-2,295
-19% -$226K
H icon
1157
Hyatt Hotels
H
$16.7B
$930K 0.01%
6,119
-21,983
-78% -$3.3M
GDV icon
1158
Gabelli Dividend & Income Trust
GDV
$2.66B
$928K 0.01%
40,881
+5,400
+15% +$121K
RXRX icon
1159
Recursion Pharmaceuticals
RXRX
$1.71B
$926K 0.01%
123,506
+81,325
+193% +$709K
PRGO icon
1160
Perrigo
PRGO
$1.8B
$926K 0.01%
36,069
+8,832
+32% +$259K
ACAD icon
1161
Acadia Pharmaceuticals
ACAD
$4.99B
$925K 0.01%
56,917
+7,241
+15% +$117K
THG icon
1162
Hanover Insurance
THG
$7.99B
$925K 0.01%
7,373
-773
-9% -$101K
UMBF icon
1163
UMB Financial
UMBF
$11.1B
$924K 0.01%
11,079
-2,606
-19% -$214K
DIOD icon
1164
Diodes
DIOD
$4.78B
$923K 0.01%
12,826
+314
+3% +$22.5K
KNSL icon
1165
Kinsale Capital Group
KNSL
$8.57B
$922K 0.01%
2,394
-7,361
-75% -$2.99M
THQ
1166
abrdn Healthcare Opportunities Fund
THQ
$793M
$922K 0.01%
45,258
+4,134
+10% +$82.2K
COO icon
1167
Cooper Companies
COO
$14.5B
$922K 0.01%
10,557
-3,607
-25% -$337K
GSK icon
1168
GSK
GSK
$106B
$920K 0.01%
23,890
+3,758
+19% +$158K
VGR
1169
DELISTED
Vector Group Ltd.
VGR
$920K 0.01%
87,012
+654
+0.8% +$6.93K
TECH icon
1170
Bio-Techne
TECH
$11.3B
$919K 0.01%
12,833
-3,022
-19% -$222K
WLY icon
1171
John Wiley & Sons Class A
WLY
$2.7B
$912K 0.01%
22,414
+1,297
+6% +$49.4K
BKE icon
1172
Buckle
BKE
$2.35B
$910K 0.01%
24,648
+11,566
+88% +$433K
INSP icon
1173
Inspire Medical Systems
INSP
$1.72B
$908K 0.01%
6,782
+397
+6% +$75.1K
ET icon
1174
Energy Transfer Partners
ET
$69.9B
$907K 0.01%
55,921
+2,188
+4% +$34.4K
IOVA icon
1175
Iovance Biotherapeutics
IOVA
$2.72B
$902K 0.01%
112,471
+35,008
+45% +$375K

Similar funds

Guggenheim Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Guggenheim Capital held 1,980 positions worth $14.1B, down 0.63% from $14.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Guggenheim Capital's Q2 2024 filing shows 111 new, 767 increased, 962 reduced and 123 closed positions. Its largest new stake was Arm: 48,961 shares worth $8.01M. The largest sale was VanEck Gold Miners ETF, an estimated $46.2M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Guggenheim Capital's largest Q2 2024 buy was Arm: 48,961 shares worth $8.01M.
  • Guggenheim Capital added most to Microsoft in Q2 2024, an estimated $17.3M increase.
  • Guggenheim Capital's biggest Q2 2024 reduction was Invesco QQQ Trust, cutting an estimated $19.6M.
  • Guggenheim Capital fully exited VanEck Gold Miners ETF in Q2 2024, selling an estimated $46.2M.
  • Guggenheim Capital's ten largest holdings make up 21% of its $14.1B portfolio in Q2 2024.
  • Guggenheim Capital opened 111 new positions and closed 123 in Q2 2024.
  • Guggenheim Capital's portfolio value fell 0.63% quarter-over-quarter to $14.1B.

Based on Guggenheim Capital's 13F filing for Q2 2024, filed 14 Aug 2024.